Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tapping technique tested to soothe Parents' nerves during baby hearing screening

NCT ID NCT07421063

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study tests whether a 15-minute Emotional Freedom Technique (EFT) session—a guided acupoint tapping routine—can reduce anxiety in mothers waiting for their newborn's first hearing screening. 70 parents will be randomly assigned to either the tapping session or a standard waiting period. Anxiety levels are measured before and after using validated scales. The goal is to see if this brief, non-drug intervention can ease the acute stress that often comes with newborn screening.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Emotional Freedom Technique (acupoint tapping)
What this could lead to
If it works, this could offer a simple, drug-free way to ease short-term anxiety for parents during newborn screening.
What could go wrong
This is a small, early-stage study with only 70 participants, so results may not apply to all parents. The anxiety reduction may be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

Mar 2026

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Mothers of neonates who are undergoing the newborn hearing screening (NHS) for the first time. * Ability to communicate effectively in the native language without language barriers. * No prior experience or training in applying the Emotional Freedom Technique (EFT). * Voluntary agreement to participate in the study and completion of the informed consent form. Exclusion Criteria: * Known history of diagnosed psychiatric disorders or epilepsy. * Situations where the neonate is crying or being breastfed immediately prior to the intervention or during the assessment. * The scheduled hearing screening procedure is initiated before the 30-35-minute study protocol is completed. * Occurrence of any acute situational triggers or environmental distractions that may interfere with the stability of anxiety measurements.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bolu Abant Izzet Baysal University, Izzet Baysal Training and Research Hospital, Newborn Hearing Screening Center

    Bolu, 14030, Turkey (Türkiye)

  • Bolu Izzet Baysal State Hospital, Newborn Hearing Screening Center

    Bolu, 14030, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.